ALPN
Alpine Immune Sciences Inc
Price:  
64.97 
USD
Volume:  
4,285,630.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ALPN Probability of Bankruptcy

The Probability of Bankruptcy of Alpine Immune Sciences Inc (ALPN) is 78.08% . This number represents the probability that ALPN will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating ALPN's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

ALPN - ESG ratings

ESG ratings are directly linked to the cost of capital and ALPN's ability to raise funding, both of which can significantly affect the probability of Alpine Immune Sciences Inc going bankrupt.

ESG Score 52.96
Environment Score 54.67
Social Score 72.69
Governance Score 31.52
Returns
Historical Returns (5 day) 0.03%
Historical Returns (MTD) 0.59%
Historical Returns (YTD) 240.87%
Historical Returns (13 week) 117.44%
Historical Returns (26 week) 431.67%
Historical Returns (52 week) 131.90%
Efficiency
Asset Turnover 0.18
Receiveable Turnover 152.33
Gross Margin
Operating Margin -322.75%
Pretax Margin -254.81%
Net Margin -254.81%
Return on Asset (ROA) -11.82
Return on Equity (ROE) -14.86
Return on Investments (ROI) -14.86
Price Metrics
Market Cap (M) 4,456.94
Enterprise Value (M)
52 Week High 65.00
52 Week Low 16.15
Beta 2.79
Average Volume (10 day) 1.79
Average Volume (3 month) 2.01
Price / Earnings (P/E)
Price / Sales (P/S) 78.86
Earnings
EPS -0.68
Revenue CAGR (5 year) 141.96%
Risk
Current Ratio 9.56
Quick Ratio 9.50